6.930USD-2.67%Mkt Cap: 724.79M USDP/E: —Last update: 2026-06-01
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docet…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap724.79M USD
Enterprise Value-34.18M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-57.39M USD
Revenue/Share—
Last Price6.930 USD
Fiscal Year EndDec 2025
MR QuarterDec 2019
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS75955J4022
Valuation
P/E (Trailing)—
P/E (Forward)-17.59
PEG—
EV/EBITDA2.47
EV/Revenue—
P/S—
P/B6.11
EPS (TTM)-1.09
EPS (Forward)-0.41
52W Range
0.520086% of range8.000
52W High8.000 USD
52W Low0.5200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-66.33%
ROA-61.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.79M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-1.07%
Net Debt-116.33M USD
Net Debt/EBITDA8.40
Balance Sheet
Debt/Equity0.10
Current Ratio80.21
Quick Ratio79.92
Book Value/Sh1.180 USD
Cash/Share10.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateSep 30, 2019
Splits
Last Split1:4
Split DateSep 30, 2019
Analyst Consensus
Rating—
Target (Mean)12.80 USD
Target Range9.000 USD – 19.00 USD
# Analysts5
Ownership
Shares Out.104.89M
Float7.72M
Insiders2.90%
Institutions87.03%
Short Interest
Short Ratio4.8d
Short % Float5.56%
Short % Out.5.23%
Shares Short5.49M
Short (prev mo.)6.19M
Technical
SMA 507.072 (-2.0%)
SMA 2004.212 (+64.5%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)976.53K
Avg Vol (10d)1.02M
Technical Indicators
RSI (14)49.8
MACD0.0144
MACD Signal0.0445
MACD Hist.-0.0301
BB Upper7.878 USD
BB Middle7.250 USD
BB Lower6.623 USD
BB Width17.31%
ATR (14)0.4244 USD
Vol Ratio (20d)0.46x